Categories AlphaGraphs, Analysis
What investors should watch when Rite Aid (RAD) reports Q3 results Thursday
As drugstore chain Rite Aid (NYSE: RAD) prepares to report third-quarter earnings, there is caution among shareholders due to the dismal performance of the stock in recent months. The results will be published on Thursday at 7:00 am ET.
Related: Rite Aid Q2 2020 Earnings Conference Call Transcript
Retail Pharmacy, the core business, is yet to recover from the continuing slump, amid falling store footfall. However, the management’s efforts to improve operational efficiency, with support from pharmacy-benefit-management division EnvisionRxOptions and the steady rise in Medicare enrollments, should boost store traffic. The increasing focus on health and wellness gives customers a better store experience, complementing the improvement in brand offerings.
In the to-be-reported quarter, the pharmacy business is expected to have benefited from Rite Aid’s partnership with Amazon (AMZN). Also, recent investments in the digital channel are paying off, which is expected to have added to revenue growth.
Cost Pressure
Nevertheless, expenses are likely to remain elevated, mainly due to spending on promotional activities to tackle competition. Another concern is the impact of new generic drugs on the retail pharmacy business, which also faces pressure from unfavorable prescription reimbursement rates.
Market watchers forecast that earnings would drop 55% annually to $0.09 per share in the third quarter. Revenues are expected to remain broadly unchanged at $5.42 billion.
Looking Back
In the second quarter, Rite Aid turned to profit from last year’s loss, despite recording flat revenues. At 12 cents per share, earnings were above analysts’ forecast. Revenues came in at $5.36 billion and fell short of expectations, reflecting weakness in the retail pharmacy business.
CEO Exit
Recently, John Standley was forced to step down as CEO, ending a nine-year stint at Rite Aid, after his efforts to arrest the stock’s free-fall and bring the company to the recovery path failed. Earlier, Rite Aid’s attempts to clinch a merger deal with Albertsons fell apart. Currently, the stakeholders are pinning hope on the company’s new chief Heyward Donigan to turn things around.
Rite Aid’s stock witnessed a persistent downturn in the past few weeks, reversing the recent gains that marked a recovery from the multi-year lows seen earlier this year. The stock has lost 55% since the beginning of the year.
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
Comments
Comments are closed.